Tag Archives: Mike Enzi

Senate Democrats Join GOP to Back ‘Automatic Austerity’ Bill That Would Gut Social Programs, Hamstring Bold Policies

“One priority of a Sanders or Warren White House absolutely must be politically crushing the deficit scolds within the Democratic Party.”

By Jake Johnson, staff writer for Common Dreams. Published 11-14-2019

Sheldon Whitehouse. Screenshot: MSNBC

A handful of Senate Democrats joined forces with Republicans last week to advance sweeping budget legislation that would establish an “automatic deficit-reduction process” that could trigger trillions of dollars in cuts to Medicare, Medicaid, food stamps, and other social programs—and potentially hobble the agenda of the next president.

The Bipartisan Congressional Budget Reform Act (S.2765), authored by Sens. Sheldon Whitehouse (D-R.I.) and Mike Enzi (R-Wyo.), passed out of the Senate Budget Committee on November 6. The legislation is co-sponsored by five members of the Senate Democratic caucus: Whitehouse, Mark Warner (Va.), Tim Kaine (Va.), Chris Coons (Del.), and Angus King (I-Maine). Continue reading

Share Button

Industry Was Doubly Generous with 13 GOP Senators Now Drafting Trumpcare

While baker’s dozen of Republicans’ all-male, all-white legislative team draft bill in secret, analysis reveals giving of insurance and pharmaceutical industries

By Common Dreams. Published 6-21-2017

According to Maplight, a watchdog that tracks campaign spending, those chosen by Majority Leader Mitch McConnell (R-Ky.) to draft the Senate’s version of Trumpcare legislation have collected, on average, $214,000 from companies that that will be directly affected by major changes to the nation’s healthcare system. (Photos: Getty Images (5); AP (5); Reuters (3))

As a group of 13 Republican senators—all of them both white and male—continue to craft in secret their version of a major healthcare overhaul bill, a new analysis shows these lawmakers have received approximately double the amount of campaign contributions from the health insurance and pharmaceutical industries than their Senate colleagues who have been so far excluded from the process. Continue reading

Share Button